Financials
Reported figures only · latest: Q4 2025
USD · US GAAP
Source: SEC XBRL filings
· latest filing
The long view
Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income9 fiscal yearsShow the numbers
| Year | Revenue | Net income |
|---|
| FY25 | $7.7M | −$17.6M |
|---|
| FY24 | $103.2K | −$33.4M |
|---|
| FY23 | $18.1M | −$18.9M |
|---|
| FY22 | $9.3M | −$80M |
|---|
| FY21 | $10.2M | −$73.2M |
|---|
| FY20 | $700.9K | −$42.4M |
|---|
| FY19 | $480K | −$16.4M |
|---|
| FY18 | $1.5M | −$15.3M |
|---|
| FY17 | - | - |
|---|
MarginsShare of revenue- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|
| FY25 | −279.5% | −229.6% |
|---|
| FY24 | −34835.4% | −32386.4% |
|---|
| FY23 | −131% | −104.6% |
|---|
| FY22 | −903.1% | −860.6% |
|---|
| FY21 | −711.2% | −719.2% |
|---|
| FY20 | −6156.5% | −6048.9% |
|---|
| FY19 | −3993.7% | −3423.4% |
|---|
| FY18 | −1147.1% | −1010.2% |
|---|
| FY17 | - | - |
|---|
Free cash flowOperating cash flow minus capital expenditureShow the numbers
| Year | Free cash flow |
|---|
| FY25 | −$15.7M |
|---|
| FY24 | −$29.7M |
|---|
| FY23 | −$28.5M |
|---|
| FY22 | −$49.3M |
|---|
| FY21 | −$45.9M |
|---|
| FY20 | −$29.5M |
|---|
| FY19 | −$18.3M |
|---|
| FY18 | −$14.8M |
|---|
| FY17 | - |
|---|
Net margin vs the sectorMedian of Healthcare companies filing with the SECShow the numbers
| Year | Adagene | Healthcare median |
|---|
| FY25 | −229.6% | −66.4% |
|---|
| FY24 | −32386.4% | −87% |
|---|
| FY23 | −104.6% | −128.5% |
|---|
| FY22 | −860.6% | −143.6% |
|---|
| FY21 | −719.2% | −137.7% |
|---|
| FY20 | −6048.9% | −134.3% |
|---|
| FY19 | −3423.4% | −125.9% |
|---|
| FY18 | −1010.2% | −172.7% |
|---|
| FY17 | - | −166.7% |
|---|
News
No stories filed under Adagene yet - coverage appears here as the news feed clusters it.